Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
FDF DOSSIERS
Reply
21 Aug 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
74
PharmaCompass offers a list of Tafamidis Meglumine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tafamidis Meglumine manufacturer or Tafamidis Meglumine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tafamidis Meglumine manufacturer or Tafamidis Meglumine supplier.
PharmaCompass also assists you with knowing the Tafamidis Meglumine API Price utilized in the formulation of products. Tafamidis Meglumine API Price is not always fixed or binding as the Tafamidis Meglumine Price is obtained through a variety of data sources. The Tafamidis Meglumine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vyndaqel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vyndaqel, including repackagers and relabelers. The FDA regulates Vyndaqel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vyndaqel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vyndaqel manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vyndaqel supplier is an individual or a company that provides Vyndaqel active pharmaceutical ingredient (API) or Vyndaqel finished formulations upon request. The Vyndaqel suppliers may include Vyndaqel API manufacturers, exporters, distributors and traders.
click here to find a list of Vyndaqel suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vyndaqel DMF (Drug Master File) is a document detailing the whole manufacturing process of Vyndaqel active pharmaceutical ingredient (API) in detail. Different forms of Vyndaqel DMFs exist exist since differing nations have different regulations, such as Vyndaqel USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vyndaqel DMF submitted to regulatory agencies in the US is known as a USDMF. Vyndaqel USDMF includes data on Vyndaqel's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vyndaqel USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vyndaqel suppliers with USDMF on PharmaCompass.
A Vyndaqel written confirmation (Vyndaqel WC) is an official document issued by a regulatory agency to a Vyndaqel manufacturer, verifying that the manufacturing facility of a Vyndaqel active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vyndaqel APIs or Vyndaqel finished pharmaceutical products to another nation, regulatory agencies frequently require a Vyndaqel WC (written confirmation) as part of the regulatory process.
click here to find a list of Vyndaqel suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vyndaqel as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vyndaqel API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vyndaqel as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vyndaqel and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vyndaqel NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vyndaqel suppliers with NDC on PharmaCompass.
Vyndaqel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vyndaqel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vyndaqel GMP manufacturer or Vyndaqel GMP API supplier for your needs.
A Vyndaqel CoA (Certificate of Analysis) is a formal document that attests to Vyndaqel's compliance with Vyndaqel specifications and serves as a tool for batch-level quality control.
Vyndaqel CoA mostly includes findings from lab analyses of a specific batch. For each Vyndaqel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vyndaqel may be tested according to a variety of international standards, such as European Pharmacopoeia (Vyndaqel EP), Vyndaqel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vyndaqel USP).
Comment (3)
